Siga Technologies INC Research and Development Expense
Siga Technologies INC (SIGA) reported Research and Development Expense of $4.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Siga Technologies INC research and development expense for the quarter ending 2026-06-30 was $4.39M, a 0.26% decline year-over-year.
- Siga Technologies INC research and development expense for the quarter ending 2026-03-31 was $3.95M, a 14.06% increase year-over-year.
- Siga Technologies INC research and development expense for the quarter ending 2025-12-31 was $5.04M, a 50.76% increase year-over-year.
- Siga Technologies INC research and development expense for the quarter ending 2025-09-30 was $7.05M, a 133.22% increase year-over-year.
- Siga Technologies INC research and development expense for fiscal 2025 was $19.96M, a 62.10% increase from fiscal 2024.
- Siga Technologies INC research and development expense for fiscal 2024 was $12.31M, a 25.06% decline from fiscal 2023.
- Siga Technologies INC research and development expense for fiscal 2023 was $16.43M, a 27.07% decline from fiscal 2022.
- Siga Technologies INC research and development expense for fiscal 2022 was $22.53M, a 126.57% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.39M 10-Q · filed 2026-08-06 | $8.34M 10-Q · filed 2026-08-06 | $13.38M derived: sum of 3 quarters · filed 2026-08-06 | $20.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.95M 10-Q · filed 2026-05-07 | $8.99M derived: sum of 2 quarters · filed 2026-05-07 | $16.05M derived: sum of 3 quarters · filed 2026-05-07 | $20.44M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $12.10M derived: sum of 2 quarters · filed 2026-03-10 | $16.49M derived: sum of 3 quarters · filed 2026-08-06 | $19.96M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $7.05M 10-Q · filed 2025-11-06 | $11.45M derived: sum of 2 quarters · filed 2026-08-06 | $14.91M 10-Q · filed 2025-11-06 | $18.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.40M 10-Q · filed 2026-08-06 | $7.86M 10-Q · filed 2026-08-06 | $11.20M derived: sum of 3 quarters · filed 2026-08-06 | $14.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.46M 10-Q · filed 2026-05-07 | $6.81M derived: sum of 2 quarters · filed 2026-05-07 | $9.83M derived: sum of 3 quarters · filed 2026-05-07 | $12.72M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.37M derived: sum of 2 quarters · filed 2026-03-10 | $9.26M derived: sum of 3 quarters · filed 2026-03-10 | $12.31M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $3.02M 10-Q · filed 2025-11-06 | $5.91M derived: sum of 2 quarters · filed 2025-11-06 | $8.97M 10-Q · filed 2025-11-06 | $11.58M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-06-30 | $2.89M 10-Q · filed 2025-08-05 | $5.94M 10-Q · filed 2025-08-05 | $8.56M derived: sum of 3 quarters · filed 2026-03-10 | $12.21M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-03-31 | $3.05M 10-Q · filed 2025-05-08 | $5.67M derived: sum of 2 quarters · filed 2026-03-10 | $9.32M derived: sum of 3 quarters · filed 2026-03-10 | $14.44M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2023-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.27M derived: sum of 2 quarters · filed 2026-03-10 | $11.38M derived: sum of 3 quarters · filed 2026-03-10 | $16.43M 10-K · filed 2026-03-10 | ||||
| 2023-09-30 | $3.65M 10-Q · filed 2024-11-07 | $8.76M derived: sum of 2 quarters · filed 2024-11-07 | $13.81M 10-Q · filed 2024-11-07 | $20.22M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | $5.12M 10-Q · filed 2024-08-01 | $10.16M 10-Q · filed 2024-08-01 | $16.57M derived: sum of 3 quarters · filed 2025-03-11 | $22.30M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | $5.05M 10-Q · filed 2024-05-07 | $11.45M derived: sum of 2 quarters · filed 2025-03-11 | $17.18M derived: sum of 3 quarters · filed 2025-03-11 | $24.02M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | $6.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $12.14M derived: sum of 2 quarters · filed 2025-03-11 | $18.98M derived: sum of 3 quarters · filed 2025-03-11 | $22.53M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | $5.73M 10-Q · filed 2023-11-07 | $12.57M derived: sum of 2 quarters · filed 2023-11-07 | $16.12M 10-Q · filed 2023-11-07 | $18.26M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-06-30 | $6.84M 10-Q · filed 2023-08-08 | $10.39M 10-Q · filed 2023-08-08 | $12.53M derived: sum of 3 quarters · filed 2024-03-12 | $15.76M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2022-03-31 | $3.55M 10-Q · filed 2023-05-04 | $5.69M derived: sum of 2 quarters · filed 2024-03-12 | $8.92M derived: sum of 3 quarters · filed 2024-03-12 | $11.19M derived: sum of 4 quarters · filed 2024-03-12 | ||||
| 2021-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $5.38M derived: sum of 2 quarters · filed 2024-03-12 | $7.64M derived: sum of 3 quarters · filed 2024-03-12 | $9.94M 10-K · filed 2024-03-12 | ||||
| 2021-09-30 | $3.24M 10-Q · filed 2022-11-03 | $5.50M derived: sum of 2 quarters · filed 2022-11-03 | $7.80M 10-Q · filed 2022-11-03 | $10.81M derived: sum of 4 quarters · filed 2023-03-02 | ||||
| 2021-06-30 | $2.26M 10-Q · filed 2022-08-04 | $4.57M 10-Q · filed 2022-08-04 | $7.57M derived: sum of 3 quarters · filed 2023-03-02 | $9.65M derived: sum of 4 quarters · filed 2023-03-02 | ||||
| 2021-03-31 | $2.30M 10-Q · filed 2022-05-05 | $5.31M derived: sum of 2 quarters · filed 2023-03-02 | $7.38M derived: sum of 3 quarters · filed 2023-03-02 | $10.09M derived: sum of 4 quarters · filed 2023-03-02 | ||||
| 2020-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.08M derived: sum of 2 quarters · filed 2023-03-02 | $7.79M derived: sum of 3 quarters · filed 2023-03-02 | $10.94M 10-K · filed 2023-03-02 | ||||
| 2020-09-30 | $2.07M 10-Q · filed 2021-11-04 | $4.78M derived: sum of 2 quarters · filed 2021-11-04 | $7.93M 10-Q · filed 2021-11-04 | $11.86M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $2.71M 10-Q · filed 2021-08-05 | $5.86M 10-Q · filed 2021-08-05 | $9.78M derived: sum of 3 quarters · filed 2021-08-05 | $13.13M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $3.15M 10-Q · filed 2021-05-06 | $7.07M derived: sum of 2 quarters · filed 2021-05-06 | $10.42M derived: sum of 3 quarters · filed 2021-05-06 | $12.46M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $3.92M 10-K · filed 2020-03-05 | $7.27M derived: sum of 2 quarters · filed 2020-11-05 | $9.31M derived: sum of 3 quarters · filed 2020-11-05 | $13.30M 10-K · filed 2022-03-03 | ||||
| 2019-09-30 | $3.34M 10-Q · filed 2020-11-05 | $5.38M derived: sum of 2 quarters · filed 2020-11-05 | $9.38M 10-Q · filed 2020-11-05 | $12.35M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $2.04M 10-Q · filed 2020-08-06 | $6.04M 10-Q · filed 2020-08-06 | $9.01M derived: sum of 3 quarters · filed 2020-08-06 | $12.73M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $4.00M 10-Q · filed 2020-05-06 | $6.97M derived: sum of 2 quarters · filed 2020-05-06 | $10.69M derived: sum of 3 quarters · filed 2020-05-06 | $14.01M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $2.97M 10-K · filed 2020-03-05 | $6.70M derived: sum of 2 quarters · filed 2020-03-05 | $10.01M derived: sum of 3 quarters · filed 2020-03-05 | $13.02M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $3.72M 10-K · filed 2020-03-05 | $3.72M 10-Q · filed 2018-11-06 | $7.04M derived: sum of 2 quarters · filed 2020-03-05 | $10.04M 10-Q · filed 2019-11-05 | $12.82M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-06-30 | $3.31M 10-K · filed 2020-03-05 | $3.31M 10-Q · filed 2018-08-07 | $6.32M 10-Q · filed 2019-08-06 | $9.10M derived: sum of 3 quarters · filed 2020-03-05 | $11.57M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-03-31 | $3.01M 10-K · filed 2020-03-05 | $3.01M 10-Q · filed 2018-05-04 | $5.79M derived: sum of 2 quarters · filed 2020-03-05 | $8.26M derived: sum of 3 quarters · filed 2020-03-05 | $13.33M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2017-12-31 | $2.78M 10-K · filed 2019-03-06 | $5.25M derived: sum of 2 quarters · filed 2019-03-06 | $10.32M derived: sum of 3 quarters · filed 2019-03-06 | $16.68M 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | $2.47M 10-K · filed 2019-03-06 | $2.47M 10-Q · filed 2017-11-07 | $7.54M derived: sum of 2 quarters · filed 2019-03-06 | $13.90M 10-Q · filed 2018-11-06 | $22.06M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-06-30 | $5.07M 10-K · filed 2019-03-06 | $5.07M 10-Q · filed 2017-08-03 | $11.43M 10-Q · filed 2018-08-07 | $19.59M derived: sum of 3 quarters · filed 2019-03-06 | $25.66M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-03-31 | $6.36M 10-K · filed 2019-03-06 | $6.36M 10-Q · filed 2017-05-04 | $14.52M derived: sum of 2 quarters · filed 2019-03-06 | $20.59M derived: sum of 3 quarters · filed 2019-03-06 | $23.54M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2016-12-31 | $8.16M 10-K · filed 2018-03-06 | $8.00K 10-K · filed 2017-03-07 | $14.23M derived: sum of 2 quarters · filed 2018-03-06 | $17.18M derived: sum of 3 quarters · filed 2018-03-06 | $19.71M 10-K · filed 2019-03-06 | |||
| 2016-09-30 | $6.07M 10-K · filed 2018-03-06 | $6.07M 10-Q · filed 2016-11-02 | $9.02M derived: sum of 2 quarters · filed 2018-03-06 | $11.55M 10-Q · filed 2017-11-07 | $16.49M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $2.95M 10-K · filed 2018-03-06 | $2.95M 10-Q · filed 2016-08-08 | $5.48M 10-Q · filed 2017-08-03 | $10.42M derived: sum of 3 quarters · filed 2018-03-06 | $12.85M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $2.54M 10-K · filed 2018-03-06 | $2.54M 10-Q · filed 2016-05-04 | $7.47M derived: sum of 2 quarters · filed 2018-03-06 | $9.90M derived: sum of 3 quarters · filed 2018-03-06 | $12.86M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $4.93M 10-K · filed 2017-03-07 | $4.93M 10-K · filed 2016-03-04 | $7.36M derived: sum of 2 quarters · filed 2017-03-07 | $10.32M derived: sum of 3 quarters · filed 2017-03-07 | $13.13M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $2.43M 10-K · filed 2017-03-07 | $2.43M 10-Q · filed 2015-10-27 | $5.39M derived: sum of 2 quarters · filed 2017-03-07 | $8.20M 10-Q · filed 2016-11-02 | $11.10M derived: sum of 4 quarters · filed 2017-03-07 | |||
| 2015-06-30 | $2.96M 10-K · filed 2017-03-07 | $2.96M 10-Q · filed 2015-08-04 | $5.77M 10-Q · filed 2016-08-08 | $5.77M 10-Q · filed 2015-08-04 | $8.67M derived: sum of 3 quarters · filed 2017-03-07 | $11.41M derived: sum of 4 quarters · filed 2017-03-07 | ||
| 2015-03-31 | $2.81M 10-K · filed 2017-03-07 | $2.81M 10-Q · filed 2015-05-06 | $5.71M derived: sum of 2 quarters · filed 2017-03-07 | $8.46M derived: sum of 3 quarters · filed 2017-03-07 | $10.83M derived: sum of 4 quarters · filed 2017-03-07 | |||
| 2014-12-31 | $2.90M 10-K · filed 2016-03-04 | $5.64M derived: sum of 2 quarters · filed 2016-03-04 | $8.02M derived: sum of 3 quarters · filed 2016-03-04 | $10.71M 10-K · filed 2017-03-07 | $10.83M 10-K · filed 2015-03-06 | |||
| 2014-09-30 | $2.74M 10-K · filed 2016-03-04 | $2.74M 10-Q · filed 2014-11-04 | $5.11M derived: sum of 2 quarters · filed 2016-03-04 | $7.83M 10-Q · filed 2015-10-27 | $7.93M 10-Q · filed 2014-11-04 | $10.75M derived: sum of 4 quarters · filed 2016-03-04 | ||
| 2014-06-30 | $2.37M 10-K · filed 2016-03-04 | $2.37M 10-Q · filed 2014-07-31 | $5.19M 10-Q · filed 2015-08-04 | $8.00M derived: sum of 3 quarters · filed 2016-03-04 | $12.27M derived: sum of 4 quarters · filed 2016-03-04 | |||
| 2014-03-31 | $2.81M 10-K · filed 2016-03-04 | $2.81M 10-Q · filed 2014-05-01 | $5.63M derived: sum of 2 quarters · filed 2016-03-04 | $9.89M derived: sum of 3 quarters · filed 2016-03-04 | $13.02M derived: sum of 4 quarters · filed 2016-03-04 | |||
| 2013-12-31 | $2.82M 10-K · filed 2015-03-06 | $7.08M derived: sum of 2 quarters · filed 2015-03-06 | $10.21M derived: sum of 3 quarters · filed 2015-03-06 | $13.79M 10-K · filed 2016-03-04 | $13.86M 10-K · filed 2014-03-10 | |||
| 2013-09-30 | $4.26M 10-K · filed 2015-03-06 | $4.26M 10-Q · filed 2013-11-06 | $7.39M derived: sum of 2 quarters · filed 2015-03-06 | $11.04M 10-Q · filed 2014-11-04 | $15.43M derived: sum of 4 quarters · filed 2015-03-06 | |||
| 2013-06-30 | $3.13M 10-K · filed 2015-03-06 | $3.13M 10-Q · filed 2013-08-05 | $6.78M 10-Q · filed 2014-07-31 | $11.17M derived: sum of 3 quarters · filed 2015-03-06 | $15.34M derived: sum of 4 quarters · filed 2015-03-06 | |||
| 2013-03-31 | $3.65M 10-K · filed 2015-03-06 | $3.65M 10-Q · filed 2013-05-15 | $8.04M derived: sum of 2 quarters · filed 2015-03-06 | $12.21M derived: sum of 3 quarters · filed 2015-03-06 | $17.39M derived: sum of 4 quarters · filed 2015-03-06 | |||
| 2012-12-31 | $4.40M 10-K · filed 2014-03-10 | $8.57M derived: sum of 2 quarters · filed 2014-03-10 | $13.75M derived: sum of 3 quarters · filed 2014-03-10 | $18.21M 10-K · filed 2015-03-06 | ||||
| 2012-09-30 | $4.17M 10-K · filed 2014-03-10 | $4.17M 10-Q · filed 2012-11-05 | $9.35M derived: sum of 2 quarters · filed 2014-03-10 | $13.82M 10-Q · filed 2013-11-06 | $19.61M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2012-06-30 | $5.18M 10-K · filed 2014-03-10 | $5.18M 10-Q · filed 2012-08-06 | $9.65M 10-Q · filed 2013-08-05 | $15.44M derived: sum of 3 quarters · filed 2014-03-10 | $20.61M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2012-03-31 | $4.46M 10-K · filed 2014-03-10 | $4.46M 10-Q · filed 2012-05-07 | $10.26M derived: sum of 2 quarters · filed 2014-03-10 | $15.43M derived: sum of 3 quarters · filed 2014-03-10 | $19.27M derived: sum of 4 quarters · filed 2014-03-10 | |||
| 2011-12-31 | $5.79M 10-K/A · filed 2013-05-15 | $5.80M 10-K · filed 2013-03-06 | $10.96M derived: sum of 2 quarters · filed 2013-05-15 | $14.80M derived: sum of 3 quarters · filed 2013-05-15 | $18.37M 10-K · filed 2014-03-10 | |||
| 2011-09-30 | $5.17M 10-K/A · filed 2013-05-15 | $5.17M 10-Q · filed 2011-11-08 | $9.01M derived: sum of 2 quarters · filed 2013-05-15 | $12.57M 10-Q · filed 2012-11-05 | $17.05M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-06-30 | $3.83M 10-K/A · filed 2013-05-15 | $3.84M 10-Q · filed 2011-08-01 | $7.40M 10-Q · filed 2012-08-06 | $11.88M derived: sum of 3 quarters · filed 2013-05-15 | $19.30M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-03-31 | $3.57M 10-K/A · filed 2013-05-15 | $3.57M 10-Q · filed 2012-05-07 | $8.05M derived: sum of 2 quarters · filed 2013-05-15 | $15.47M derived: sum of 3 quarters · filed 2013-05-15 | $20.40M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2010-12-31 | $4.48M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-05-15 | $11.90M derived: sum of 2 quarters · filed 2013-05-15 | $16.83M derived: sum of 3 quarters · filed 2013-05-15 | $22.66M 10-K/A · filed 2013-05-15 | ||||
| 2010-09-30 | $7.42M 10-Q · filed 2011-11-08 | $12.35M derived: sum of 2 quarters · filed 2011-11-08 | $18.18M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $4.93M 10-Q · filed 2011-08-01 | $10.76M 10-Q · filed 2011-08-01 | ||||||
| 2009-12-31 | $17.42M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |